Breast Neoplasms: all 12,820 studies
Page 106 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.
- Exploratory, Phase I,Open Label,Non-randomized Study of [F18]CP-18 PET in Normal and Breast Cancer SubjectsTerminatedNCT01362712Phase 1
- AUY922 With Lapatinib and Letrozole for ER+ HER2+ Advanced Breast CancerWithdrawnNCT01361945Phase 1/2
- Radioactive Iodide (131I) Treatment of 124I PET/CT Detected Breast CancersWithdrawnNCT01360177Not applicable
- Evaluation of the Effects of Chinese Medical Treatment on Leucopenia After Chemotherapy in Breast Cancer PatientsStatus unknownNCT01359501Phase 2
- Trial of Low Dose Tamoxifen in Women With Breast Intraepithelial Neoplasia - Long Term Follow-upActive, not recruitingNCT01357772Phase 3
- Pasireotide LAR Administration in Lymphocele Prevention After Axillary Node Dissection for Breast CancerCompletedNCT01356862Phase 2
- Vaccine Therapy in Combination With Rintatolimod and/or Sargramostim in Treating Patients With Stage II-IV HER2-Positive Breast CancerCompletedNCT01355393Phase 1/2
- TAC Versus TCX as Adjuvant Treatment for High-risk Her2-Negative Breast CancerCompletedNCT01354522Phase 3
- Neoadjuvant Chemotherapy With Docetaxel and Gemcitabine in Locally Advanced Breast CancerStatus unknownNCT01352494Phase 2
- Adjuvant AI Combined With ZoladexStatus unknownNCT01352091Phase 3
- Sentinel Node Biopsy in Breast Cancer PatientsCompletedNCT01351974
- Cyclophosphamide and Veliparib in Treating Patients With Locally Advanced or Metastatic Breast CancerActive, not recruitingNCT01351909Phase 1
- The CEASE Study: Computer Based Educational Module for the Reduction of Arthralgia Syndrome Associated With Endocrine Therapy for Breast CancerTerminatedNCT01351844Not applicable
- A Clinical Trial of Docetaxel and Oxaliplatin in Patients With Recurrent or Metastatic Breast CancerStatus unknownNCT01351597Phase 2
- Tumour Registry Breast CancerCompletedNCT01351584
- Investigational Drug in Combination With Two Chemotherapy Drugs in Women With Locally Recurrent or Metastatic Breast CancerWithdrawnNCT01349088Phase 1/2
- Biomarkers in Tissue Samples From Older Women With Breast CancerTerminatedNCT01346579
- Suppression of Bone Turnover Following Treatment With Zoledronic Acid in Patients With Metastatic Breast Cancer: Duration of EffectCompletedNCT01344967Phase 2/3
- A Pilot Study of Tumor-Derived Exosomes as Diagnostic and Prognostic Markers in Breast Cancer Patients Receiving Neoadjuvant ChemotherapyWithdrawnNCT01344109
- MK2206 in Combination With Anastrozole, Fulvestrant, or Anastrozole and Fulvestrant in Treating Postmenopausal Women With Metastatic Breast CancerCompletedNCT01344031Phase 1
- Blood Test for Breast Cancer Associated Auto AntibodiesStatus unknownNCT01343849
- Prospective Radiologic Evaluation of Changes Following Fat GraftingCompletedNCT01343030
- An Online Psychoeducational Intervention for Young Women With Breast Cancer and Their PartnersCompletedNCT01342302Not applicable
- The Impact of Tamoxifen and Aromatase Inhibitors on Platelet ProteinsCompletedNCT01341171
- Neoadjuvant 5-fluorouracil, Epirubicin and Cyclophosphamide (FEC) Followed by Weekly Paclitaxel and Trastuzumab in Her2 Positive Breast CancerCompletedNCT01340430Phase 2
- BKM120 and Fulvestrant for Treating Postmenopausal Patients With Estrogen Receptor-Positive Stage IV Breast CancerCompletedNCT01339442Phase 1
- Teleconference Group: Breast Cancer in African Americans (STORY)CompletedNCT01339351Not applicable
- Phase I Study of LFA102 in Patients With Prolactin Receptor-positive Castration-resistant Prostate Cancer or Prolactin Receptor-positive Metastatic Breast CancerCompletedNCT01338831Phase 1
- Study to Evaluate Markers of Response in Locally Advanced Breast CancerCompletedNCT01338753Phase 2
- Effectiveness of a Decision Support System in Improving the Diagnosis and Screening Rate of Breast CancerStatus unknownNCT01336257Not applicable
- Online Stress Management and Coping Skills Training for Women With Breast CancerCompletedNCT01335152Phase 1/2
- Safety Study of Radiation and CP-675,206 Infusion for Breast Cancer PatientsTerminatedNCT01334099Phase 1
- Impact on Cognitive Function and Quality of Life of Adjuvant Chemotherapy in Patients Aged Over 65 Years: Application to Breast Cancer or ColonCompletedNCT01333735
- Maximum Tolerated Dose (MTD) of Liposomal Doxorubicin in Combination With Seliciclib for Patients With Metastatic Triple Negative Breast Cancer (TNBC)WithdrawnNCT01333423Phase 1
- A Clinical Trial Comparing Gemcitabine and Carboplatin With and Without P276-00 in Subjects With Metastatic Triple Negative Breast Cancer, With a Run-in of Escalating Dose of P276-00 Added to Gemcitabine and CarboplatinTerminatedNCT01333137Phase 1
- Impact of Cancer on Memory Functioning: Understanding Disorders Using Approaches in Neuropsychology and NeuroimagingTerminatedNCT01332916Phase 2
- Promoting Breast Cancer Screening in Non-adherent WomenCompletedNCT01332032
- Impact of Nutritional Intervention in Women With Breast Cancer Under Adjuvant ChemotherapyCompletedNCT01331772Not applicable
- Impact of Art Therapy on Fatigue and Quality of Life of Patients Treated With Adjuvant Radiotherapy for Breast CancerCompletedNCT01331629Phase 2/3
- Feasibility Study of Metronomic Chemotherapy for Locally Advanced Her2- Positive Breast Cancer (TraQ-Me 01)TerminatedNCT01329640Phase 2
- Feasibility Study of Metronomic Chemotherapy for Locally Advanced HER2-Negative Breast CancerTerminatedNCT01329627Phase 2
- Patient Empowerment by Group Medical ConsultationsStatus unknownNCT01329068Not applicable
- Z-Endoxifen Hydrochloride in Treating Patients With Metastatic or Locally Recurrent Estrogen Receptor-Positive Breast CancerActive, not recruitingNCT01327781Phase 1
- Enumeration and Molecular Characterization of Circulating Tumour Cells in Women With Metastatic Breast CancerCompletedNCT01322893
- Adjuvant Whole Breast Radiotherapy (RT) With Intensity Modulated Radiotherapy (IMRT) and a Simultaneous Integrated Boost Versus Conventional RT and a Sequential BoostStatus unknownNCT01322854Phase 3
- Circulating Tumor Cells (CTCs): A Potential Screening Test for Clinically Undetectable Breast CarcinomaStatus unknownNCT01322750
- Adapted Physical Activity Effect and Fatigue in Patients With Breast CancerCompletedNCT01322412
- Bevacizumab and Trastuzumab With Weekly Paclitaxel Followed, After Surgery, by Encapsuled Liposomal Doxorubicin, Cyclophosphamide and Trastuzumab as Adjuvant Treatment After Surgery on Women With Her2+ Breast CancerStatus unknownNCT01321775Phase 2
- PD0332991/Paclitaxel in Advanced Breast CancerCompletedNCT01320592Phase 1
- 4R for Guideline Indicated BRCA Testing of Breast Center PatientsCompletedNCT01320540
- Breast Cancer in Young Women: Is it Different?SuspendedNCT01320488
- Breast Cancer Study: Paclitaxel Versus Paclitaxel Plus Sorafenib in Second- or Third-line TreatmentCompletedNCT01320111Phase 2
- Prognostic and Predictive Impact of uPA/PAI-1CompletedNCT01317108Phase 3
- Determination of Predictive Genetic Markers of Toxicity After Hypofractionated Radiotherapy in Breast Cancer Patients Post-Conservative SurgeryCompletedNCT01316328
- High Resolution 3D Diffusion-weighted Breast MRITerminatedNCT01315106
- Breast Cancer Screening With MRI in Women Aged 50-75 Years With Extremely Dense Breast Tissue: the DENSE TrialCompletedNCT01315015Not applicable
- Minus Anthracycline or Short-Term Versus Epirubicin and Cyclophosphamide Followed by Paclitaxel Regimen for Adjuvant Breast Cancer TherapyCompletedNCT01314833Phase 3
- The Combination of GnRh Analogue and Aromatase Inhibitor in Receptor Positive Premenopausal Women With Advanced Breast CancerStatus unknownNCT01311037
- Partial Breast Proton Therapy for Early Stage Breast CancerActive, not recruitingNCT01310530Not applicable
- Study of Preoperative Weekly Paclitaxel and Carboplatin With Lapatinib (Tykerb®) in Patients With ErbB2-Positive Stage I-III Breast CancerStatus unknownNCT01309607Phase 2
- Comparing (SIS.NET) to Standard Care in Patients Who Have Completed the Acute Phase of Treatment for Early Breast CancerCompletedNCT01308775Not applicable
- Study of the P16 Gene as a Predictor of Myelosuppression in Breast Cancer PatientsCompletedNCT01305954
- Getting Back on Track: An Educational Group for Women With Breast CancerCompletedNCT01305915Not applicable
- Safety and Pharmacokinetic Study of MM-302 in Patients With Advanced Breast CancerStatus unknownNCT01304797Phase 1
- Effects of Short-term Fasting on Tolerance to ChemotherapyCompletedNCT01304251Not applicable
- 1st Line Treatment of Bevacizumab-Taxane vs Bevacizumab-Exemestane in Metastatic Breast CancerTerminatedNCT01303679Phase 3
- C11 AMT Positron Emission Tomography (PET) Imaging in Patients With Metastatic Invasive Breast CancerWithdrawnNCT01302821Not applicable
- The Use of Metformin in Early Breast Cancer Patients Pre-SurgeryWithdrawnNCT01302002Early Phase 1
- Study of Cipatinib in Patients With HER2 Positive or Uncertain Advanced Breast CancerTerminatedNCT01301911Phase 1
- Early Cardiac Toxicity of Adjuvant CT in Elderly BC.TerminatedNCT01301040Phase 2
- Study of BKM120 or BYL719 and Capecitabine in Patients With Metastatic Breast CancerCompletedNCT01300962Phase 1
- Alopecia Secondary to Endocrine Therapy in Postmenopausal Women With Breast CancerTerminatedNCT01300871
- Prospective Phase II Study of Intraoperative Radiotherapy (IORT) in Elderly Patients with Small Breast CancerCompletedNCT01299987Not applicable
- Breast Cancer Prevention EducationCompletedNCT01299623Not applicable
- Tamoxifen-RAD001 Versus Tamoxifen Alone in Patients With Anti-aromatase Resistant Breast Metastatic CancerCompletedNCT01298713Phase 2
- Prospective Analysis of Changes in Background Parenchymal Enhancement (BPE) and Amount of Fibroglandular Tissue on Breast MRIWithdrawnNCT01297231
- Cancer Survivor Registry: The Breast Cancer M.A.P. (Mind Affects the Physical) ProjectCompletedNCT01295658
- The Effects of Radiation in Reconstructed BreastsCompletedNCT01292772
- Autophagy Inhibition Using Hydrochloroquine in Breast Cancer PatientsStatus unknownNCT01292408Phase 2
- Breast Health in Chinese American WomenCompletedNCT01292200Not applicable
- Azacitidine in Treating Patients With Triple Negative Stage I-IV Invasive Breast Cancer That Can Be Removed By SurgeryWithdrawnNCT01292083Not applicable
- Whole-body MR in Staging Bone and Soft Tissue Metastases in Breast Cancer Patients(MetaMaRBo)Status unknownNCT01291082
- Conformal Partial Breast Irradiation With CyberKnife After Resection for Early Stage Breast CancerCompletedNCT01290835Not applicable
- Paclitaxel and Bavituximab in Treating Patients With HER2-Negative Metastatic Breast CancerCompletedNCT01288261Phase 1
- BEZ235 Trial in Patients With HER2-(Human Epidermal Growth Factor Receptor 2 Negative) /HR+ (Hormonal Receptor Positive) Metastatic Breast CancerWithdrawnNCT01288092Phase 2
- Gemcitabine Plus Cisplatin Versus Gemcitabine Plus Paclitaxel in Triple Negative Breast Cancer (TNBC)CompletedNCT01287624Phase 3
- Academia Sinica Investigator Award 2010Status unknownNCT01287468
- Study of Biomarkers Associated With Fatigue in Patients With Early-Stage Breast Cancer Treated With Metformin or Placebo on NCIC-CTG-MA.32Status unknownNCT01286233
- Lapatinib and RAD-001 for HER2 Positive Metastatic Breast CancerStatus unknownNCT01283789Phase 2
- Patient-reported Outcome Questionnaire for Women With Metastatic Breast CancerCompletedNCT01282931
- Dietary Fish and Omega 3 Fatty Acids for Breast Cancer PreventionCompletedNCT01282580Phase 1
- Acupressure for Persistent Cancer Related FatigueCompletedNCT01281904Phase 2/3
- Bevacizumab With Etoposide and Cisplatin in Breast Cancer Patients With Brain and/or Leptomeningeal MetastasisCompletedNCT01281696Phase 2
- Lapatinib Ditosylate and Akt Inhibitor MK2206 in Treating Women With Metastatic Breast CancerTerminatedNCT01281163Phase 1
- Veliparib in Combination With Carboplatin and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid TumorsCompletedNCT01281150Phase 1
- Radiotherapy After Primary Chemotherapy for BreastcancerCompletedNCT01279304
- Persistent Pain After Breast Cancer Treatment With DocetaxelCompletedNCT01279018
- Phase I Study of Novel Estrogen Receptor(ER) a36 Modifier Icaritin in Advanced Breast Cancer PatientsStatus unknownNCT01278810Phase 1
- Patterns of Care in Hormone-receptor Positive, Advanced Breast CancerTerminatedNCT01277926
- Pilot Study of Secondary Causes of Osteopenia/Osteoporosis in Adults With Breast and Prostate CancerCompletedNCT01277562